4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-022863
Director sold 8,904 shares at $40.00 ($356,171)
- Director acquired 8,904 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tsuchimoto Kim R Director | 2025-07-14 | Option exercise | +8,904 | $0.01 | $45 | 20,390 | D |
| Tsuchimoto Kim R Director | 2025-07-14 | Sale | −8,904 | $40.00 | $356,171 | 11,486 | D |
| Derivatives | |||||||
| Tsuchimoto Kim R Director | 2025-07-14 | Option exercise · Stock Options | −4,200 | 0 | D | ||
| Tsuchimoto Kim R Director | 2025-07-14 | Option exercise · Stock Options | −4,704 | 0 | D | ||
| Open-market sales · 8,904 sh · avg $40.00 · $356,171 | |||||||
Loading xslF345X05/rdgdoc.xml…